Polypeptides of Leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof
US7888492B2 · kind B2 · utility
0Cited by
0References
10Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 7, 2006 |
| Grant date | Feb 15, 2011 |
| Priority date | — |
| Expiry date | Apr 7, 2026 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to new proteins of Leishmania major and to therapeutical and diagnostic applications thereof. More particularly, the present invention relates to excreted/secreted polypeptides and polynucleotides encoding same, compositions comprising the same, and methods of diagnosis, vaccination and treatment of Leishmaniasis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.